West Paces Advisors’s Edwards Lifesciences EW Stock Holding History

West Paces Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.98K	Buy	+33	New	+$2.76K	﹤0.01%	525
2022 Q4	–	Sell	-72	Closed	-$5.95K	–	542
2022 Q3	$5.95K	Hold	72	–	–	﹤0.01%	377
2022 Q2	$6.85K	Hold	72	–	–	﹤0.01%	392
2022 Q1	$8.48K	Hold	72	–	–	﹤0.01%	380
2021 Q4	$9.33K	Sell	72 -30	-29%	-$3.5K	﹤0.01%	383
2021 Q3	$11.5K	Hold	102	–	–	﹤0.01%	346
2021 Q2	$10.6K	Hold	102	–	–	﹤0.01%	353
2021 Q1	$8.53K	Hold	102	–	–	﹤0.01%	345
2020 Q4	$9.3K	Hold	102	–	–	﹤0.01%	323
2020 Q3	$8.14K	Hold	102	–	–	﹤0.01%	322
2020 Q2	$7.05K	Hold	102	–	–	﹤0.01%	344
2020 Q1	$6.41K	Hold	102	–	–	﹤0.01%	340
2019 Q4	$7.93K	Hold	102	–	–	﹤0.01%	370
2019 Q3	$7.48K	Hold	102	–	–	﹤0.01%	352
2019 Q2	$6.28K	Hold	102	–	–	﹤0.01%	361
2019 Q1	$6.5K	Hold	102	–	–	﹤0.01%	361
2018 Q4	$5.21K	Hold	102	–	–	﹤0.01%	374
2018 Q3	$5.92K	Hold	102	–	–	﹤0.01%	366
2018 Q2	$4.95K	Buy	102 +30	+42%	+$1.4K	﹤0.01%	385
2018 Q1	$3.35K	Hold	72	–	–	﹤0.01%	396
2017 Q4	$2.71K	Sell	72 -84	-54%	-$3.08K	﹤0.01%	416
2017 Q3	$5.68K	Sell	156 -69	-31%	-$2.63K	﹤0.01%	378
2017 Q2	$8.87K	Hold	225	–	–	0.01%	349
2017 Q1	$7.05K	Sell	225 -27	-11%	-$845	0.01%	362
2016 Q4	$7.87K	Buy	+252	New	+$8.16K	0.01%	363

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

West Paces Advisors's EW Position: Q2 2026 in Review

West Paces Advisors opened a new position in Edwards Lifesciences (EW) in Q2 2026: 33 shares worth $2.98K. The stake represents ﹤0.01% of the portfolio and ranks #525 among its holdings. This is a return to the name: West Paces Advisors previously reported a position in EW as recently as Q3 2022.

West Paces Advisors first reported a position in EW in Q4 2016 and has held it in 25 quarters since. The position peaked at $11.5K in Q3 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

West Paces Advisors held 33 shares of Edwards Lifesciences worth $2.98K as of Q2 2026.
Edwards Lifesciences was a new West Paces Advisors position in Q2 2026.
Edwards Lifesciences made up ﹤0.01% of West Paces Advisors's portfolio in Q2 2026, its #525 holding.
West Paces Advisors first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 25 quarters since.
West Paces Advisors's Edwards Lifesciences position peaked at $11.5K in Q3 2021.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.